share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Mar 4 17:54
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.
Arcutis Biotherapeutics, Inc. officer Todd Franklin Watanabe is set to sell 14,903 shares of common stock on 03/04/2024, with an aggregate market value of $165,739. The shares to be sold were recently acquired through restricted stock vesting on 03/01/2024 and 03/03/2024, totaling 14,903 shares. This transaction follows a recent sale of 2,465 shares by Watanabe on 02/28/2024, which grossed $26,129.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more